{
  "id": 10947097,
  "title": "Visioneering Technologies’ New Contact Lens Trial Shows Landmark Results in Slowing Children’s Nearsightedness",
  "url": "https://urgent.news/2026/09/30/visioneering-technologies-new-contact-lens-trial-shows-landmark",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T13:14:21.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/visioneering-technologies-new-contact-lens-trial-shows-landmark-results-in-slowing-childrens-nearsightedness"
  },
  "original_language": "en",
  "account": null,
  "summary": "Completed three-year PROTECT randomized controlled trial finds NaturalVue Multifocal 1 Day contact lens slowed myopia progression by 1.06 diopters and eye elongation by 0.58 mm at 36 months.1,2 ANAHEIM, Calif. — Visioneering Technologies, Inc. (VTI), a medical device company that designs and markets specialty contact lenses, will announce completed three-year results from PROTECT, a prospective,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}